COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers

被引:20
|
作者
Katz, J. M. [1 ]
Libman, R. B. [1 ]
Wang, J. J. [3 ]
Filippi, C. G. [2 ]
Sanelli, P. [2 ]
Zlochower, A. [2 ]
Gribko, M. [1 ]
Pacia, S., V [1 ]
Kuzniecky, R., I [1 ]
Najjar, S. [1 ]
Azhar, S. [1 ]
机构
[1] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Neurol, Hempstead, NY 11549 USA
[2] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Radiol, Hempstead, NY 11549 USA
[3] Feinstein Inst Med Res Northwell Hlth, Manhasset, NY USA
关键词
D O I
10.3174/ajnr.A6920
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Coronavirus disease 2019 (COVID-19) appears to be an independent risk factor for stroke. We hypothesize that patients who develop stroke while hospitalized for severe COVID-19 will have higher inflammatory markers and distinct stroke imaging patterns compared with patients positive for COVID-19 with out-of-hospital stroke onset and milder or no COVID-19 symptoms. MATERIALS AND METHODS: This is a retrospective case series of patients positive for COVID-19 on polymerase chain reaction testing with imaging-confirmed stroke treated within a large health care network in New York City and Long Island between March 14 and April 26, 2020. Clinical and laboratory data collected retrospectively included complete blood counts and creatinine, alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin, and D-dimer levels. All CT and MR imaging studies were independently reviewed by 2 neuroradiologists who recorded stroke subtype and patterns of infarction and intracranial hemorrhage. RESULTS: Compared with patients with COVID-19 with outside-of-hospital stroke onset and milder or no COVID-19 symptoms (n?=?45, 52.3%), patients with stroke already hospitalized for severe COVID-19 (n?=?41, 47.7%) had significantly more frequent infarctions (95.1% versus 73.3%, P?=?.006), with multivascular distributions (56.4% versus 33.3%, P?=?.022) and associated hemorrhage (31.7% versus 4.4%, P?=?.001). Patients with stroke admitted with more severe COVID-19 had significantly higher C-reactive protein and ferritin levels, elevated D-dimer levels, and more frequent lymphopenia and renal and hepatic injury (all, P?<?.003). CONCLUSIONS: Patients with stroke hospitalized with severe COVID-19 are characterized by higher inflammatory, coagulopathy, and tissue-damage biomarkers, supporting proposed pathogenic mechanisms of hyperinflammation activating a prothrombotic state. Cautious balancing of thrombosis and the risk of hemorrhagic transformation is warranted when considering anticoagulation.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 50 条
  • [21] Plasma markers of COVID-19 severity: a pilot study
    Julia Beimdiek
    Sabina Janciauskiene
    Sabine Wrenger
    Sonja Volland
    Adriana Rozy
    Jan Fuge
    Beata Olejnicka
    Isabell Pink
    Thomas Illig
    Alexander Popov
    Joanna Chorostowska
    Falk F. R. Buettner
    Tobias Welte
    Respiratory Research, 23
  • [22] Association of biochemical markers with COVID-19 severity in Pakistan
    Iqbal, Rashid
    Niazi, Muhammad Aamir Khan
    Shabbir, Muhammad Usman
    Raza, Umama
    Saleem, Alina
    Bhatti, Theophilus
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (07) : 1403 - 1407
  • [23] Adipokines as Diagnostic and Prognostic Markers for the Severity of COVID-19
    Grewal, Thomas
    Buechler, Christa
    BIOMEDICINES, 2023, 11 (05)
  • [24] Laboratory Biomarkers Associated with Severity and Mortality of COVID-19
    Allarakia, Basmah M. Azad
    Gattan, Hattan
    Al-Ahmadi, Bassam M.
    Abdeen, Rawan H.
    Bazaid, Mohammed B.
    Shater, Abdullah F.
    Jalal, Mohammed M.
    Saeedi, Nizar H.
    Mohammedsaleh, Zuhair M.
    Altayar, Malik A.
    Alreshidi, Maha
    Bazaid, Abdulrahman S.
    CLINICAL LABORATORY, 2022, 68 (02) : 291 - 297
  • [25] Laboratory Biomarkers Associated with Severity and Mortality of COVID-19
    Allarakia, Basmah M. Azad
    Gattan, Hattan
    Al-Ahmadi, Bassam M.
    Abdeen, Rawan H.
    Bazaid, Mohammed B.
    Shater, Abdullah F.
    Jalal, Mohammed M.
    Saeedi, Nizar H.
    Mohammedsaleh, Zuhair M.
    Altayar, Malik A.
    Alreshidi, Maha
    Bazaid, Abdulrahman S.
    CLINICAL LABORATORY, 2021,
  • [26] Laboratory biomarkers associated with COVID-19 severity and management
    Keddie, S.
    Ziff, O.
    Chou, M. K. L.
    Taylor, R. L.
    Heslegrave, A.
    Garr, E.
    Lakdawala, N.
    Church, A.
    Ludwig, D.
    Manson, J.
    Scully, M.
    Nastouli, E.
    Chapman, Md
    Hart, M.
    Lunn, Mp
    CLINICAL IMMUNOLOGY, 2020, 221
  • [27] Correlation between chest CT severity scoring system with oxygen saturation and laboratory inflammatory markers in adult patients with COVID-19 infection
    Ahmed Gamil Ibrahim Abd El Megid
    Mohamed El Shabrawy
    Ahmed Abd El-Hamid Mohamed Abdalla
    Egyptian Journal of Radiology and Nuclear Medicine, 53
  • [28] Correlation between chest CT severity scoring system with oxygen saturation and laboratory inflammatory markers in adult patients with COVID-19 infection
    Megid, Ahmed Gamil Ibrahim Abd El
    El Shabrawy, Mohamed
    Abdalla, Ahmed Abd El-Hamid Mohamed
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2022, 53 (01):
  • [29] Mild versus severe COVID-19: Laboratory markers
    Velavan, Thirumalaisamy P.
    Meyer, Christian G.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 95 : 304 - 307
  • [30] Cardiac Arrhythmias and COVID-19: Correlation With Disease Severity
    Mahdi, Mohammed
    Bezawada, Vineel
    Ozer, Muhammet
    De Deyne, Patrick
    Nagra, Bipinpreet
    Kantharia, Bharat
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)